17.15
Toxidromes: Clinical Features
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The…
Toxidromes are distinct symptom patterns signaling drug or chemical overdose. Their recognition enables rapid diagnosis and treatment.
The most common toxidromes are anticholinergic, cholinergic, opioid, sympathomimetic, sedative and hypnotic.
Anticholinergic toxidrome results from muscarinic receptor inhibition and parasympathetic suppression causing dry flushed skin, hyperthermia, mydriasis, delirium, and reduced intestinal motility.
Cholinergic agents inhibit acetylcholinesterase, causing acetylcholine accumulation and muscarinic overstimulation.
Cholinergic toxidrome causes somnolence, coma, miosis, excessive salivation, diarrhea, gastric cramping, emesis, and muscle twitching.
Opioid overdose suppresses the CNS, typically causing miosis, respiratory depression, bradycardia, and reduced gut motility.
Next, sympathomimetic toxidrome results from sympathetic stimulation, leading to agitation, hypertension, tachycardia, mydriasis, tremors, sweating, and hyperthermia.
Sedatives and hypnotics cause drowsiness, respiratory depression, and diminished reflexes.
View the full transcript and gain access to JoVE Core videos
Q1: What are toxidromes and why do healthcare providers need to recognize them?
Toxidromes are distinct symptom patterns that signal drug or chemical overdose, enabling rapid diagnosis and treatment. Recognition of these patterns is critical for healthcare providers to manage poisoning effectively and initiate appropriate pharmaceutical poisoning treatment strategies quickly.
Q2: What causes anticholinergic toxidrome and what are its clinical features?
Anticholinergic toxidrome results from muscarinic receptor inhibition and parasympathetic suppression. Clinical features include dry flushed skin, hyperthermia, mydriasis (dilated pupils), delirium, and reduced intestinal motility. Drugs like atropine and diphenhydramine commonly cause this pattern.
Q3: How does cholinergic toxidrome develop and what symptoms does it produce?
Cholinergic toxidrome occurs when agents inhibit acetylcholinesterase, causing acetylcholine accumulation and muscarinic overstimulation. Symptoms include somnolence, coma, miosis (constricted pupils), excessive salivation, diarrhea, gastric cramping, emesis, and muscle twitching. Organophosphates are a common cause.
Q4: What distinguishes sympathomimetic toxidrome from other toxidromes?
Sympathomimetic toxidrome results from sympathetic nervous system stimulation, producing agitation, hypertension, tachycardia, mydriasis, tremors, sweating, and hyperthermia. Cocaine and amphetamines commonly cause this pattern, which contrasts with depressant toxidromes that reduce vital signs.
Q5: What respiratory and cardiovascular effects characterize opioid overdose?
Opioid overdose suppresses the central nervous system, typically causing miosis, respiratory depression, bradycardia, and reduced gut motility. These effects result from opioid receptor activation and can rapidly become life-threatening if not treated promptly.
Q6: How do sedative and hypnotic toxidromes affect the central nervous system?
Sedatives and hypnotics depress central nervous system activity, causing drowsiness, respiratory depression, and diminished reflexes. Benzodiazepines and barbiturates are common examples that produce this depressant toxidrome pattern affecting multiple organ systems.
Q7: What are the six most common toxidromes encountered in clinical practice?
The six most common toxidromes are anticholinergic, cholinergic, opioid, sympathomimetic, sedative-hypnotic, and salicylate. Each produces a distinct symptom cluster reflecting the drug class's mechanism of action on the nervous system and vital functions.